会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • DIAGNOSTIC IMAGING CONTRAST AGENT WITH IMPROVED IN-SERUM-RELAXIVITY
    • 诊断成像对比剂具有改善的血清 - 松弛度
    • WO1998005625A1
    • 1998-02-12
    • PCT/EP1997004096
    • 1997-07-28
    • BRACCO S.P.A.DIBRA S.P.A.CALABI, LuisellaMAIOCCHI, AlessandroLOLLI, MarcoREBASTI, Fabrizio
    • BRACCO S.P.A.DIBRA S.P.A.
    • C07C229/16
    • C07C229/26A61K49/06C07C229/36C07C229/76C07D209/20
    • Compounds of formula (I), either in their racemic or enantiomeric forms, wherein R is H or a C1-C20 alkyl chain, which may be interrupted by O, N, S, -CO-, -CH(OH)-, -CH(NH2)-, -CONH-, -NHCO-, -SO-, -SO2-, -SO2NH-, may be substituted by halogen atoms or -COOH groups or their ester or amide derivatives and which is interrupted or not or substituted or not by one or more cyclic R3 residues. R3 is a 5- or 6-membered optionally substituted carbocyclic or heterocyclic, saturated, unsaturated or aromatic cyclic unit, R1, R2 have the same meanings as R, independently from each other, except H, with the proviso that: when R1 and R2 are both C6H5-CH2-O-CH2-, R is different from either H or C6H5-CH2-O-CH2-; as well as the complexes of the compounds of formula (I) with metal ions and the salts thereof with physiologically acceptable organic bases. The compounds are used in the preparation of diagnostic imaging contrast agents and in particular of contrast agents exhibiting improved serum relaxivity.
    • 式(I)化合物,以其外消旋或对映体形式,其中R为H或C 1 -C 20烷基链,其可被O,N,S,-CO-, - CH(OH) - , - CH(NH 2) - , - CONH - , - NHCO - , - SO - , - SO 2 - , - SO 2 NH-可以被卤素原子或-COOH基团或其酯或酰胺衍生物取代, 或不由一个或多个环状R 3残基。 R 3是5或6元任选取代的碳环或杂环,饱和,不饱和或芳族环状单元,R 1,R 2具有与R相同的含义,彼此独立地除H外,条件是:当R 1和R 2 均为C 6 H 5 -CH 2 -O-CH 2 - ,R不同于H或C 6 H 5 -CH 2 -O-CH 2 - ; 以及式(I)化合物与金属离子及其盐与生理上可接受的有机碱的配合物。 该化合物用于制备诊断成像造影剂,特别是显示出改进的血清舒张性的造影剂。